Objective. To present and vote on a myositis modified patient-reported outcome core domain set in the life impact area at the Outcome Measures in Rheumatology (OMERACT) 2018. Methods. Based on results from international focus groups and Delphi surveys, a draft core set was developed. Results. Domains muscle symptoms, fatigue, level of physical activity, and pain reached ≥ 70% consensus and were mandatory to assess in all trials. Domains lung, joint, and skin symptoms were mandatory in specific circumstances. This core set was endorsed by > 85% at OMERACT 2018. Conclusion. We propose a life impact core set for patients with idiopathic inflammatory myopathies and will proceed with instrument selections
Objective. The Outcome Measures in Rheumatology (OMERACT) polymyalgia rheumatica (PMR) working group...
OBJECTIVE: To devise new tools to assess activity and damage in patients with idiopathic myopathies ...
Objective. Patient-reported outcome measures (PROM) that incorporate the patient perspective have no...
Background/Purpose: The OMERACT Myositis special interest group (SIG) represents clinicians, patient...
Objective. To inform development of a core domain set for outcome measures for clinical trials in po...
OBJECTIVE: To inform development of a core domain set for outcome measures for clinical trials in po...
Objective. The current Juvenile Idiopathic Arthritis (JIA) Core Set used in randomized controlled tr...
Objective. To update the 1997 OMERACT-OARSI (Outcome Measures in Rheumatology-Osteoarthritis Researc...
Objective To update the 1997 OMERACT-OARSI (Outcome Measures in Rheumatology-Osteoarthritis Research...
Objective. The Outcome Measures in Rheumatology (OMERACT) Shared Decision Making (SDM) Working Group...
Objective To investigate the content validity of several patient-reported outcome measures (PROMs) ...
Objective. The Outcome Measures in Rheumatology (OMERACT) Shared Decision Making (SDM) Working Group...
Objective: The Outcome Measures in Rheumatology (OMERACT) polymyalgia rheumatica (PMR) working group...
Objective To reach consensus on the core domains to be included in a core domain set for clinical tr...
The Journal of Rheumatology Copyright © 2016. All rights reserved. Objective. The Outcome Measures i...
Objective. The Outcome Measures in Rheumatology (OMERACT) polymyalgia rheumatica (PMR) working group...
OBJECTIVE: To devise new tools to assess activity and damage in patients with idiopathic myopathies ...
Objective. Patient-reported outcome measures (PROM) that incorporate the patient perspective have no...
Background/Purpose: The OMERACT Myositis special interest group (SIG) represents clinicians, patient...
Objective. To inform development of a core domain set for outcome measures for clinical trials in po...
OBJECTIVE: To inform development of a core domain set for outcome measures for clinical trials in po...
Objective. The current Juvenile Idiopathic Arthritis (JIA) Core Set used in randomized controlled tr...
Objective. To update the 1997 OMERACT-OARSI (Outcome Measures in Rheumatology-Osteoarthritis Researc...
Objective To update the 1997 OMERACT-OARSI (Outcome Measures in Rheumatology-Osteoarthritis Research...
Objective. The Outcome Measures in Rheumatology (OMERACT) Shared Decision Making (SDM) Working Group...
Objective To investigate the content validity of several patient-reported outcome measures (PROMs) ...
Objective. The Outcome Measures in Rheumatology (OMERACT) Shared Decision Making (SDM) Working Group...
Objective: The Outcome Measures in Rheumatology (OMERACT) polymyalgia rheumatica (PMR) working group...
Objective To reach consensus on the core domains to be included in a core domain set for clinical tr...
The Journal of Rheumatology Copyright © 2016. All rights reserved. Objective. The Outcome Measures i...
Objective. The Outcome Measures in Rheumatology (OMERACT) polymyalgia rheumatica (PMR) working group...
OBJECTIVE: To devise new tools to assess activity and damage in patients with idiopathic myopathies ...
Objective. Patient-reported outcome measures (PROM) that incorporate the patient perspective have no...